Compare BKE & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BKE | PBH |
|---|---|---|
| Founded | 1948 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.8B |
| IPO Year | 1992 | 2005 |
| Metric | BKE | PBH |
|---|---|---|
| Price | $57.50 | $59.78 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $55.00 | ★ $86.40 |
| AVG Volume (30 Days) | 383.3K | ★ 433.6K |
| Earning Date | 11-21-2025 | 11-06-2025 |
| Dividend Yield | ★ 6.82% | N/A |
| EPS Growth | ★ 3.79 | N/A |
| EPS | ★ 4.09 | 4.04 |
| Revenue | ★ $1,277,894,000.00 | $1,110,479,000.00 |
| Revenue This Year | $8.24 | N/A |
| Revenue Next Year | $3.26 | $2.50 |
| P/E Ratio | ★ $13.99 | $14.80 |
| Revenue Growth | ★ 4.67 | N/A |
| 52 Week Low | $33.12 | $57.25 |
| 52 Week High | $61.69 | $90.04 |
| Indicator | BKE | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 55.82 | 47.52 |
| Support Level | $55.60 | $59.19 |
| Resistance Level | $57.80 | $61.69 |
| Average True Range (ATR) | 1.62 | 1.55 |
| MACD | 0.11 | 0.24 |
| Stochastic Oscillator | 86.14 | 58.45 |
Buckle Inc is a retailer of casual apparel, footwear, and accessories. The company retails medium to affordable priced casual apparel, footwear, and accessories for fashion-conscious young men and women. It retails under the brand names 'Buckle' and 'The Buckle'. Buckle markets a wide selection of mostly brand-name casual apparel including denim, other casual bottoms, tops, sportswear, outerwear, accessories, and footwear.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.